The future of AI in powering clinical trial innovation
summary
Pharma shows almost $4 billion raised in early-stage AI drug discovery, 64 FDA‑cleared AI devices catalogued by 2020, and a projection that 70% of trials use wearable sensors by 2025. Concrete tools include big‑data site selection, NLP screening of EHRs to match patients to trials, digital twin models proposed to shrink placebo arms, and cloud platforms replacing manual source‑data verification. AbbVie has run wrist/ankle sensors since 2016 to quantify Parkinson’s motor control; an atopic dermatitis study combines wearables and actigraphy with a sleep headband to detect nocturnal scratching.
AI-written summary · about
chapters (12)
- 0:00Introduction
- 0:58Recent market trends
- 1:48Canadas AI strategy
- 4:14Clinical trials
- 5:10Challenges
- 6:35Overview
- 7:20Addressing recruitment delays
- 9:33AI powered solutions
- 11:11Wearables
- 12:13Digital endpoints
- 14:51Cloudbased platforms
- 16:42Summary
related talks
13mAI-Powered Clinical Trials
35mHow may AI help you? - healthcare
50mA Sustainable Future for Learning AI in Healthcare
23mAI in the Life Science Sector
36mReimagining the Future of Clinical Trials
47mThe Future of Healthcare and AI
28mAI in healthcare - Deep learning for precision psychiatry
01h 14mChallenges for Leveraging the Potential of Digital Technology in Medi